Northwestern Mutual Wealth Management’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-24,559
Closed -$36.6K 3861
2025
Q1
$36.6K Buy
+24,559
New +$29.5K ﹤0.01% 2289

Other funds holding LUCD

Northwestern Mutual Wealth Management's LUCD Position: Q2 2025 in Review

Northwestern Mutual Wealth Management sold out of Lucid Diagnostics (LUCD) in Q2 2025, closing a stake of 24,559 shares — an estimated $36.6K sold.

Northwestern Mutual Wealth Management first reported a position in LUCD in Q1 2025 and held it in 1 quarter. The position peaked at $36.6K in Q1 2025. 72 funds tracked by Wall St. Rank hold LUCD as of Q2 2025.

  • Northwestern Mutual Wealth Management reported no remaining Lucid Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 24,559 Lucid Diagnostics shares in Q2 2025, an estimated $36.6K.
  • Northwestern Mutual Wealth Management first reported a position in Lucid Diagnostics in Q1 2025 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Lucid Diagnostics position peaked at $36.6K in Q1 2025.
  • 72 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.